SEARCH

SEARCH BY CITATION

References

  • Burrows, D. and Bassett, B. (1996) Meeting the Needs of People in Australia Living with hepatitis C. Canberra: Commonwealth Department of Health and Family Services.
  • Bury, M. (1982) Chronic illness as biographical disruption, Sociology of Health and Illness, 4, 2, 16782.
  • Carricaburu, D. and Pierret, J. (1995) From biographical disruption to biographical reinforcement: the case of HIV-positive men, Sociology of Health and Illness, 17, 1, 6588.
  • Davis, M. and Rhodes, T. (2004) Beyond prevention? Injecting drug user narratives about hepatitis C, International Journal of Drug Policy, 15, 12331.
  • Davis, M., Rhodes, T. and Martin, A. (2004) Preventing hepatitis C: ‘common sense’, ‘the bug’ and other perspectives from the risk narratives of people who inject drugs, Social Science and Medicine, 59, 9, 180718.
  • Dore, G. (2001) Natural history of hepatitis C virus infection. In Crofts, N., Dore, G. and Locarnini, S. (eds) Hepatitis C: An Australian Perspective. Melbourne: IP Communications.
  • Duffin, J. (2005) Lovers and Livers: Disease Concepts in History. Toronto and London: University of Toronto Press.
  • Elliott, A. and Chapman, S. (2000) ‘Heroin hell their own making’: construction of heroin users in the Australian press 1992-97, Drug and Alcohol Review, 19, 191201.
  • Ellis, C. and Berger, L. (2001) Their story/my story/our story: including the researchers' experience in interview research. In Golbrium, J. and Holstien, J. (eds), Handbook of Interview Research: Context and Method. Thousand Oaks, London and New Delhi: Sage.
  • Emerson, E. (1992) What is normalisation? In Brown, H. and Smith, H. (eds) Normalisation: a Reader for the Nineties. London and New York: Tavistock/Routledge.
  • Faircloth, C., Boylstein, C., Rittman, M., Young, M. and Gubrium, J. (2004) Sudden illness and biographical flow in narratives of stroke recovery, Sociology of Health and Illness, 26, 2, 24261.
  • Fraser, S. (2004) ‘It’s your life!’: injecting drug users, individual responsibility and hepatitis C prevention, Health, 8, 2, 199221.
  • Gifford, S., O’Brien, M., Bammer, G., Banwell, C. and Stoove, M. (2003) Australian women’s experiences of living with hepatitis C virus: results from a cross-sectional survey, Journal of Gastroenterology and Hepatology, 18, 84150.
  • Gill, M., Atiq, M., Sattar, S. and Khokhar, N. (2005) Psychological implications of hepatitis C virus diagnosis, Journal of Gastroenterology and Hepatology, 20, 11, 17414.
  • Glacken, M., Kernohan, G. and Coates, V. (2001) Diagnosed with hepatitis C: a descriptive exploratory study, International Journal of Nursing Studies, 38, 10716.
  • Green, S., Davis, C., Karshmer, E., Marsh, P. and Straight, B. (2005) Living stigma: the impact of labeling, stereotyping, separation, status loss, and discrimination in the lives of individuals with disabilities and their families, Sociological Inquiry, 75, 2, 197215.
  • Grow, J. and Christopher, S. (2008) Breaking the silence surrounding hepatitis C by promoting self-efficacy: hepatitis C public service announcements, Qualitative Health Research, 18, 10, 140112.
  • Harris, M. (2005) Living with hepatitis C: the medical encounter, New Zealand Sociology, 20, 1, 419.
  • Hepworth., J. and Krug, G. (1999) Hepatitis C: a socio-cultural perspective on the effects of a new virus on a community’s health, Journal of Health Psychology, 4, 2, 23746.
  • Hopwood, M. and Treloar, C. (2003) The 3D Project: Diagnosis, Disclosure, Discrimination and Living with hepatitis C. Sydney: National Centre in HIV Social Research.
  • Hopwood, M. and Treloar, C. (2004) Receiving a hepatitis C-positive diagnosis, Internal Medicine Journal, 34, 9, 52631.
  • Kemp, R. (2003) The Experience of Needle and Syringe Provision in Australia and New Zealand: a Comparative Analysis. Paper presented at the national conference on injecting drug use 2003.
  • Kleinman, A. (1988) The Illness Narratives: Suffering, Healing and the Human Condition. USA: Basic Books.
  • Krug, G. (1995) Hepatitis C: discursive domains and epistemic chasms, Journal of Contemporary Ethnography, 24, 3, 299322.
  • Leder, D. (1990) The Absent Body. Chicago and London: The University of Chicago Press.
  • Mathieson, C. and Stam, H. (1995) Renegotiating identity: cancer narratives, Sociology of Health and Illness, 17, 3, 283306.
  • National Centre in HIV Epidemiology and Clinical Research. (2008). HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia Annual Surveillance Report 2008. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales.
  • New Zealand Ministry of Health (2002) Action on hepatitis C Prevention. Wellington: New Zealand Ministry of Health.
  • Pound, P., Gompertz, P. and Ebrahim, S. (1998) Illness in the context of older age: the case of stroke, Sociology of Health and Illness, 20, 4, 489506.
  • Rose, N. (1996) Inventing our Selves: Psychology, Power and Personhood. Cambridge: Cambridge University Press.
  • Sanders, C., Donovan, J. and Dieppe, P. (2002) The significance and consequences of having painful and disabled joints in older age: co-existing accounts of normal and disrupted biographies, Sociology of Health and Illness, 24, 2, 22753.
  • Steedman, S. and Zobair, Y. (2000) Hepatitis C: an update on the silent epidemic, Journal of Clinical Gastroenterology, 30, 2, 12543.
  • Williams, S. (2000) Chronic illness as biographical disruption or biographical disruption as chronic illness? Sociology of Health and Illness, 22, 1, 4067.
  • Wilson, S. (2007) ‘When you have children, you’re obliged to live’: motherhood, chronic illness and biographical disruption, Sociology of Health and Illness, 29, 4, 61026.
  • World Health Organisation (2002) Hepatitis C. Fact-sheet number 164. Downloaded 14 April 2007 from http://www.who.int/mediacentre/factsheets/fs164/en.
  • Wozniak, L., Prakash, M., Taylor, M. and Wild, T. (2007) Everybody’s got it, but...: situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada, International Journal of Drug Policy, 18, 5, 38896.